Cancer Screening Panel, Women

The Cancer Screening Panel for Women consists of 5 tumor markers to help diagnose and monitor cancer, predict its behavior, and check for recurrence after treatment.

Description

What is the purpose of this test?

Order this Cancer Screening Panel for Women, which consists of 5 tumor markers to help diagnose and monitor cancer, predict its behavior, and check for recurrence after treatment. Cancer screening tests can detect cancer or pre-cancerous areas before symptoms appear. Cancer treatments are most successful when cancer is found early. Based on family cancer history and genetic mutations, healthcare providers can screen for some cancers during a yearly wellness check-up. Breast, cervical, colorectal, skin, thyroid, and uterine cancer screenings may be necessary, depending on personal/family history or smoking habits.

This panel screens for the following tumor markers:

Carcinoembryonic Antigen (CEA) - CEA levels are measured before and after surgery for colon cancer to check the success of treatment and chances of recovery. It is also used to monitor chemotherapy's effectiveness and detect if cancer has returned after treatment.

Cancer Antigen 19-9 (CA 19-9) - The CA 19-9 test measures the amount of a protein in the blood as a type of tumor marker. High levels of CA 19-9 can indicate pancreatic cancer, but can also be a sign of other cancers or non-cancerous conditions. The test is not used alone for diagnosis, but can help monitor cancer and treatment progress.

Cancer Antigen 125 (CA-125) - The CA-125 blood test measures a protein that can be a sign of cancer. High levels of CA-125 are often found in people with ovarian cancer. The test can help show whether treatment is working.

Alpha-Fetoprotein (AFP) - The AFP tumor marker test measures AFP levels in the blood. It can help diagnose certain cancers and monitor treatment. High levels may indicate liver, ovarian, or testicular cancer, but it cannot be used alone for diagnosis. AFP levels can also be high in other conditions or normal in some cancer cases. The test is most effective when used with other exams.

Cancer Antigen 15-3 (CA 15-3) - The CA 15-3 test monitors the recurrence and spread of breast cancer. If the CA 15-3 level is elevated, it indicates the potential spread or recurrence of breast cancer. Typically, this test is performed alongside CA 125 and CEA. It is important to note that this test is not intended for screening breast cancer.

When should I order a Cancer Screening Panel, Women?

Individuals may order this test if they have experienced symptoms related to a specific type of cancer. This panel is especially useful for individuals with a personal/family history of cancer. Common signs and symptoms of cancer for women may include:

• Abnormal periods or pelvic pain
• Bloating
• Bowel changes
• Breast changes, such as lumps
• Chronic coughing
• Chronic headache
• Difficulty swallowing
• Excessive bruising